Cargando…
Medulloblastoma stem cells: Promising targets in medulloblastoma therapy
Medulloblastoma (MB) is the most common malignant pediatric brain tumor. Despite great improvements in the therapeutic regimen, relapse and leptomeningeal dissemination still pose great challenges to the long‐term survival of MB patients. Developing more effective strategies has become extremely urg...
Autores principales: | Huang, Guo‐Hao, Xu, Qing‐Fu, Cui, You‐Hong, Li, Ningning, Bian, Xiu‐Wu, Lv, Sheng‐Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970825/ https://www.ncbi.nlm.nih.gov/pubmed/27171351 http://dx.doi.org/10.1111/cas.12925 |
Ejemplares similares
-
Metabolic determinants of stemness in medulloblastoma
por: Martín-Rubio, Paula, et al.
Publicado: (2022) -
The application of fluorescein sodium for the resection of medulloblastoma
por: Chen, Zheng-he, et al.
Publicado: (2022) -
Targeting the Hedgehog Pathway in Pediatric Medulloblastoma
por: Huang, Sherri Y., et al.
Publicado: (2015) -
The KDM1A histone demethylase is a promising new target for the epigenetic therapy of medulloblastoma
por: Pajtler, Kristian W, et al.
Publicado: (2013) -
Illuminating Medulloblastoma
por: Rastan, Avesta, et al.
Publicado: (2019)